Therasense Financials
We advise to exercise Therasense fundamental analysis to find out if markets are presently mispricing the firm. In other words this technique allows you to confirm available indicators of Therasense as well as the relationship between them. We were able to analyze and collect data for twenty-seven available drivers for Therasense, which can be compared to its competition.
Therasense |
Therasense Stock Summary
Therasense competes with Scisparc, Creative Medical, Sonnet Biotherapeutics, Inhibikase Therapeutics, and Tempest Therapeutics. Theralink Technologies, Inc., a commercial-stage precision medicine and molecular data-generating company, engages in the development and commercialization of novel cancer immunotherapy products. Theralink Technologies, Inc. was formerly known as OncBioMune Pharmaceuticals, Inc. and changed its name to Theralink Technologies, Inc. in September 2020. Theralink Technologies operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 16 people.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| Business Address | 15000 West 6th |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | theralink.com |
| Phone | 720 420 0074 |
| Currency | USD - US Dollar |
Therasense Key Financial Ratios
There are many critical financial ratios that Therasense's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Therasense reports annually and quarterly.| Return On Asset | -169.9 | |||
| Number Of Employees | 16 | |||
| Beta | 22.12 | |||
| Z Score | -1.4 |
Therasense Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Therasense's current stock value. Our valuation model uses many indicators to compare Therasense value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Therasense competition to find correlations between indicators driving Therasense's intrinsic value. More Info.Therasense is rated second in return on asset category among its peers. It is currently regarded number one company in current valuation category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Therasense's earnings, one of the primary drivers of an investment's value.Therasense Systematic Risk
Therasense's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Therasense volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourty-two with a total number of output elements of nineteen. The Beta measures systematic risk based on how returns on Therasense correlated with the market. If Beta is less than 0 Therasense generally moves in the opposite direction as compared to the market. If Therasense Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Therasense is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Therasense is generally in the same direction as the market. If Beta > 1 Therasense moves generally in the same direction as, but more than the movement of the benchmark.
Additional Tools for Therasense Pink Sheet Analysis
When running Therasense's price analysis, check to measure Therasense's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Therasense is operating at the current time. Most of Therasense's value examination focuses on studying past and present price action to predict the probability of Therasense's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Therasense's price. Additionally, you may evaluate how the addition of Therasense to your portfolios can decrease your overall portfolio volatility.